: A randomized, placebo-controlled trial of the safety and efficacy of tecovirimat for the treatment — LORI DODD (LEIDOS BIOMEDICA
The funding supports a clinical trial to identify effective treatments for monkeypox virus disease. Monkeypox virus is a re-emerging pathogen that causes monkeypox virus disease, a disease of epidemic
| Project title | : A randomized, placebo-controlled trial of the safety and efficacy of tecovirimat for the treatment |
|---|---|
| Project number | 75N91019D00024-P00001-759102000025-5 |
| PI name | LORI DODD |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $9.82M |
| Fiscal year | 2021 |
| Project start | 2020-09-28T00:00:00 |
| Project end | 2025-09-27T00:00:00 |
| Abstract | The funding supports a clinical trial to identify effective treatments for monkeypox virus disease. Monkeypox virus is a re-emerging pathogen that causes monkeypox virus disease, a disease of epidemic |
| Key terms | <Africa><Africa South of the Sahara><Belgian Congo><Biological Terrorism><Bioterrorism><Cessation of |
$799/mo
Try GrantRadar →